2024.06.13
HighLife® Transseptal Mitral Valve Repla···
From June 5 to 7, 2024, the New York Valves (NYV) conference was held, where Prof. Nicolo Piazza of ···
2024.06.13
MonarQ™ Transcatheter Tricuspid Valve Re···
From June 5 to 7, 2024, the latest results of the FIM clinical implantation of MonarQTM, an innovati···
2024.04.22
PEIJIA MEDICAL SHONE AT TWO MAJOR STRUC···
On March 18-24 and April 15-20, 2024, Peijia Medical shone at the 5th China Structural Heart Disease···
2024.04.19
NEW AV21 SPECIFICATION: PEIJIA MEDICAL’S···
On April 18, 2024, new AV21 specification of TaurusOne® and TaurusElite® TAVR systems, developed by ···
2024.04.15
INNOVATIVE TRANSCATHETER EDGETO-EDGE RE···
On April 12, 2024, the results of GeminiOne® for DMR were published in JACC: Case Reports, a leading···
2024.03.29
Trilogy™ THV SYSTEM FOR AR INDICATION: R···
On March 26, 2024, the exciting results of JenaValve TrilogyTM System’s pivotal clinical trial, ALIG···
2024.03.01
TaurusNXT® NON-GLUTARALDEHYDE CROSSLINKE···
In February 2024, TaurusNXT® Non-glutaraldehyde Crosslinked dry-tissue TAVR system, a thirdgenerati···
2024.02.01
TaurusAtlas Pro, THE SECOND-GENERATION B···
The registration application of TaurusAtlas Pro, the second-generation balloon dilatation catheter i···
2024.01.29
TaurusTrio AR TAVR SYSTEM COMPLETED ALL ···
In January 2024, TaurusTrio AR TAVR System successfully completed patient enrollment in its mu···
2023.12.29
Academic Conferences at Home and Abroad ···
❖ TaurusOne® Transcatheter Aortic Valve Replacement (TAVR) System■ Four-Year Clinical Follow-up Resu···
2023.12.22
Shanghai Renji Hospital Completed the Fi···
Achieva Medical initiated a prospective, multi-center, randomized-controlled clinical trial to evalu···
2023.11.01
Prof. Yu Bo's Team at the Second Affilia···
On October 31, 2023, the team led by Prof. Yu Bo at the Second Affiliated Hospital of Harbin Medical···